Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET097 in Adults With Obesity or Overweight
NCT06712836Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2024
- Primary completion
- Jul 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PF-08653944 in obesity, sponsored by Pfizer. Started Oct 2024; status: completed.
02
Drugs
PF-08653944
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06712836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712836.